期刊文献+

VEGF对白血病树突状细胞抗原提呈能力的影响 被引量:5

Effect of VEGF on antigen presentation capability of leukemic dendritic cells and its mechanism
暂未订购
导出
摘要 目的探讨血管内皮生长因子(vascular endothelial cell growth factor,VEGF)对白血病源树突状细胞(dendrit-ic cell,DC)抗原提呈能力的影响及其分子机制。方法K562细胞经5μmol/LVEGF反义寡核苷酸(AS-ODN)处理24h,ELISA和免疫组化检测VEGF蛋白水平。以正常K562细胞诱生的白血病DC作为对照组,利用流式细胞术和混合淋巴细胞反应,观察AS-ODN处理的白血病DC的免疫表型及其刺激T细胞增殖的能力。采用荧光素酶检测系统和RT-PCR分析培养12h时白血病DC内NF-κB转录活性和Flt-1mRNA水平。结果AS-ODN处理使K562细胞VEGF蛋白分泌量较K562细胞组显著下降(P<0.05)。与K562-DC比较,AS-ODN处理的免疫表型(CD40、CD86、CD83、HLA-DR)表达明显上调。在不同DC/T值(1:10~1:40)时,MLR实验中AS-K562-DC组刺激指数(SI)明显高于对照组(P<0.05)。此外,培养12h时AS-K562-DCNF-κB转录活性较K562-DC明显增高(P<0.05),而Flt-1mRNA水平未见明显改变。结论反义寡核苷酸可抑制白血病细胞VEGF表达,下调VEGF能够增强白血病DC免疫表型的表达,提高DC抗原提呈能力。 Objective To investigate the effect of vascular endothelial growth factor (VEGF) on antigen presentation capability of dendritic ceils (DCs) derived from leukemic cell line. Methods After treated by 5 μmol/L VEGF antisense oligodeoxynucleotide (AS-ODN) for 24 h, VEGF protein expression of K562 cells was measured by ELISA and immunohistochemistry. Taking DCs induced from K562 as control, the biological characteristics of leukemic DCs derived from K562 treated by AS-ODN were examed. Flow cytometry was used to detect the expressions of immunophenotypes. The proliferative ability of T ceils stimulated by DCs was analyzed by mixed lymphocyte reaction assay. Moreover, luciferase assay system was used to monitor the transcription activity of NF-κB and RT-PCR to detect Flt-1 mRNA expression at the end of 12-hour culture. Results VEGF protein secretion of treated K562 decreased remarkably compared to K562 cell ( P 〈 0.05 ). Compared to K562- DC group, the expressions of immunophenotypes including CD40, CD83, CD86 and HLA-DR in leukemic DCs group increased remarkably. The stimulating index (SI) of MLR in leukemic DCs group was significantly higher than that in the control group in different ratio of DC/T ( 1:10 to 1:40 ) respectively ( P 〈0.05 ). At the end of 12-hour culture, the transcription activity of NF-κB of leukemic DCs was significantly higher (P 〈0. 05 ), but Flt-1 mRNA level had no obvious change. Conclusion VEGF AS-ODN could inhibit VEGF protein level in leukemic cells in vitro. Downregulating VEGF could enhance the immunophenotype expressions of DCs derived from the leukemic cells and improve their antigen presentation capability.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2007年第16期1587-1590,共4页 Journal of Third Military Medical University
基金 重庆市教委科学技术研究基金(KJ050309)~~
关键词 白血病 血管内皮生长因子 反义寡核苷酸 树突状细胞 核因子ΚB leukemia vascular endothelial growth factor antisense oligodeoxynucleotide dendritic cells nuclear factor κB
  • 相关文献

参考文献10

  • 1Gabrilovich D I,Chen H L,Girgis K R,et al.Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells[J].Nat Med,1996,2(10):1096-1103.
  • 2Boissel N,Rousselot P,Raffoux E,et al.Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate[J].Leukemia,2004,18(10):1656-1661.
  • 3张伶,陈辉,李维,涂植光,冯文莉,黄宗干.血管内皮生长因子及其Flt-1受体在白血病细胞中的表达[J].第三军医大学学报,2004,26(8):678-681. 被引量:8
  • 4Gabrilovich D,Ishida T,Oyama T,et al.Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo[J].Blood,1998,92(11):4150-4166.
  • 5童向民,金洁,钱文斌,孟海涛,薛永权.慢性髓系白血病来源的树突状细胞生物学特性的研究[J].浙江大学学报(医学版),2005,34(4):348-352. 被引量:5
  • 6Eisendle K,Lang A,Eibl B,et al.Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia[J].Br J Haematol,2003,120(1):63-73.
  • 7Gabrilovich D I,Ishida T,Nadaf S,et al.Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function[J].Clin Cancer Res,1999,5(10):2963-2970.
  • 8Dikov M M,Ohm J E,Ray N,et al.Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation[J].J Immunol,2005,174(1):215-222.
  • 9Laxmanan S,Robertson S W,Wang E,et al.Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways[J].Biochem Biophys Res Commun,2005,334(1):193-198.
  • 10Oyama T,Ran S,Ishida T,et al.Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells[J].J Immunol,1998,160(3):1224-1232.

二级参考文献16

  • 1ROBINSON N S P,JAJU R.De in-vitro generation of dendritic cells from blast cells acute leukemia [J].Br J Haematol,1998,103:763- 771.
  • 2BROUWER R E,HOORN M V,HANNKE C.The generation of dendritic-like cells with increased func allostimulatorytion from acute myeloid leukemia cells of various FAB subclasses [J].Hum Immunol,2000,61:565-574.
  • 3SCHWARTZ J,PINILLA-IBARZ J,YUAN R R.Novel targeted and immun otherapeutic strategies in chronic myeloid leukemia [J].Semin Hematol ,2003,40(1):87-96.
  • 4HEUFLER C,KOCH F,STANZL U.Interleukin-12 is produced by dend ritic cells and mediates Thelper 1 development as well as interferon-gamma production by Thelper 1 cells [J].Eur J Immunol,1996,26(3):659-668.
  • 5Aguayo A, Kantarjian H, Manshoori T, et al. Angiagenesis in acute and chronic leukemias and myeledysplastic syndromes[J]. 2Blood, 2000, 96(6): 2240 - 2245.
  • 6Chen H, Treweeke A T, West D C, et al. In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells[J]. 2Blood, 2000, 96 (9): 3181 -3187.
  • 7Dias S, Hattori K, Zhu Z P, et al. Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration[J]. J Clin Invest, 2000,106(4): 511-521.
  • 8Aguayo A, Manshouri T, O' Brien S, et cd. Clinical relevance of Fltl and Tiel angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL)[J]. Leuk Res, 2001, 25(4): 279-285.
  • 9Fiedler W, Graeven U, Ergun S, et cd. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia[J]. Blood, 1997, 89(6): 1870-1875.
  • 10Bellamy W T, Richter L, Frutiger Y, et al. Expression of vascular endothelial cell growth factor and its receptors in hematopoietic malignancies[ J].Cancer Res, 1999, 59(3): 728 - 733.

共引文献11

同被引文献56

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部